• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • Not To Miss
  • FDA Approvals
  • Events By OncoDaily
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Celebrities and Cancer
  • Immune Oncology
  • Breast Oncology
  • Gastrointestinal Oncology
  • Lung Oncology
  • Hematology
  • Radiotherapy
  • Cancer Types
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Services
  • Privacy Policy
  • Contact Us
Double Left Left Aug / 2026 Right Double Right
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
« Jul    
OncodailyJournal CancerWorld
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Voices
  • Not To Miss
  • FDA Approvals
  • Events By OncoDaily
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

AstraZeneca and Daiichi Sankyo’s Enhertu Improves PFS in First-Line HER2-Mutant Advanced NSCLC in Phase III DESTINY-Lung04

International Urology Cancer Summit and OncoDaily Announce Strategic Partnership

Using Lung Function Data to Refine Pulmonary Toxicity Risk Before Thoracic Radiotherapy

10 Must-Read Posts In GU Oncology This Week

DESTINY-Lung04: Enhertu Improves First-Line PFS in HER2-Mutant NSCLC

AstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig Plus Chemotherapy in Metastatic NSCLC

Evelyn H. Lauder at 90: A Legacy That Transformed Breast Cancer Research

Vivek Subbiah: Rethinking the Unified Cancer of Unknown Primary Concept

OncoCalendar

6 events found.

Resonance

« All Events
Website https://resonancehealth.org/

Events from this organizer

Today
  • January 2026

  • Fri 30
    Journal Club with Scott

    Journal Club with Scott Howard – Resonance

    Jan 30 • 9:00 AM - 10:00 AM
    Virtual Event

    The ALRCaN Global webinar series presents "Journal Club with Scott," featuring Dr. Scott Howard on Friday, January 30, 2026, from 09:00 AM to 10:00 AM EST. Hosted by Resonance Health, the journal club serves as a collaborative platform for healthcare professionals to analyze new data, discuss emerging trends, and share diverse perspectives on optimizing patient […]

  • February 2026

  • Fri 6
    CNS Directed Therapy

    CNS Directed Therapy: No Quick Fixes – Resonance

    Feb 6 • 9:00 AM - 10:00 AM
    Virtual Event

    The ALRCaN Global webinar, titled "CNS Directed Therapy: No Quick Fixes," is scheduled for Friday, February 6, 2026, from 09:00 AM to 10:00 AM ET. This session features a lively discussion led by Dr. Ajay Vora on the complexities and challenges associated with CNS-directed treatments. Organized by ALRCaN Global and Resonance Health, the event is […]

  • Fri 13
    Relapsed B-ALL

    Novel Reinduction Strategies for Relapsed B-ALL – Resonance

    Feb 13 • 9:00 AM - 10:00 AM
    Virtual Event

    The ALRCaN Global webinar, titled "Novel reinduction strategies for relapsed B-ALL," is scheduled for Friday, February 13, 2026, at 09:00 AM ET. This session features Dr. Laura E. Hogan, who will lead a lively discussion on innovative approaches to reinduction therapy for patients with relapsed B-cell acute lymphoblastic leukemia. Organized through Resonance Health and created […]

  • Fri 20
    CAR T-Cell Therapy

    CAR T-Cell Therapy to Transplant: Evolving Therapy for AYA Leukemia – Resonance

    Feb 20 • 9:00 AM - 10:00 AM
    Virtual Event

    The ALRCaN Global webinar, titled "CAR T-Cell Therapy to Transplant: Evolving Therapy for AYA Leukemia," is scheduled for Friday, February 20, 2026, at 09:00 AM ET. Featuring Dr. Hannah Lust, the session will focus on the evolving treatment landscape for Adolescent and Young Adult (AYA) patients, specifically examining the transition and relationship between CAR T-cell […]

  • Fri 27
    AML

    Outcomes of Adolescent and Young Adult Patients with AML Treated on Adult Versus Pediatric Protocols – Resonance

    Feb 27 • 9:00 AM - 10:00 AM
    Virtual Event

    The ALRCaN Global webinar, titled "Outcomes of adolescent and young adult patients with AML treated on adult versus pediatric protocols," is scheduled for Friday, February 27, 2026, at 09:00 AM ET. Featuring Dr. Ira Kraft, the session will explore the comparative therapeutic outcomes for Adolescent and Young Adult (AYA) patients with Acute Myeloid Leukemia (AML) […]

  • March 2026

  • Fri 6
    Resonance

    CART19-BE-02 trial: From Bench to Bedside and Beyond – Resonance

    Mar 6 • 9:00 AM - 10:00 AM
    Virtual Event

    The ALRCaN Global webinar, titled “CART19-BE-02 trial: From Bench to Bedside and Beyond—Implementing a Hospital-Based CAR T Program and Integrating It into the Spanish NHS,” is scheduled for Friday, March 06, 2026, at 09:00 AM ET (06:00 PM Armenia Standard Time). Featuring Dr. Valentín Ortiz-Maldonado, the session will explore the clinical implementation and integration of […]

  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

LinkedIn X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat
Oncology OncoDaily cancer Breast Cancer cancer care ASCO fight against cancer Lung cancer Global fight against cancer Cancer research Headlines immunotherapy ESMO NSCLC cancer treatment MD Anderson Cancer Center cancer awareness clinical trials colorectal cancer Research prostate cancer FDA Childhood Cancer AACR UICC ASCO24 chemotherapy Dana-Farber Cancer Institute radiation oncology Pancreatic Cancer American Cancer Society Robert Orlowski SIOP American Society of Clinical Oncology European Cancer Organisation AI NCI Myeloma Paper of the Day National Cancer Institute Paolo Tarantino WHO cervical cancer Vivek Subbiah Myeloma Precision Oncology radiotherapy IASLC bladder cancer multiple myeloma Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}